TOX and squamous cell lung carcinoma: Similarly, the survival analysis of TCGA NSCLC cohort (LUAD, lung adenocarcinoma, and LUSC, lung squamous cell carcinoma) revealed that a high overall survival rate was associated with low TOX expression level in the T cells (P = 0.0393, log-rank test) (Fig. 5d).